Key result
MicroRNA machine learning models accurately classify endocrine hypertension from primary hypertension with ~0.9 AUC.
Why the study?
Does circulating microRNA profiling combined with machine learning accurately classify endocrine hypertension subtypes compared to primary hypertension?
Observational
Does circulating microRNA profiling combined with machine learning accurately classify endocrine hypertension subtypes compared to primary hypertension?
Answers are grounded in this paper and cite their sources.
Circulating microRNAs analyzed via machine learning can accurately distinguish endocrine hypertension from primary hypertension with AUCs of 0.8 to 0.9.
OBJECTIVE: Hypertension is a major cardiovascular risk factor affecting about 1 in 3 adults. Although the majority of hypertension cases (∼90%) are classified as "primary hypertension" (PHT), endocrine hypertension (EHT) accounts for ∼10% of cases and is caused by underlying conditions such as primary aldosteronism (PA), Cushing's syndrome (CS), pheochromocytoma or paraganglioma (PPGL). EHT is often misdiagnosed as PHT leading to delays in treatment for the underlying condition, reduced quality of life and costly, often ineffective, antihypertensive treatment. MicroRNA (miRNA) circulating in the plasma is emerging as an attractive potential biomarker for various clinical conditions due to its ease of sampling, the accuracy of its measurement and the correlation of particular disease states with circulating levels of specific miRNAs. METHODS: This study systematically presents the most discriminating circulating miRNA features responsible for classifying and distinguishing EHT and its subtypes (PA, PPGL, and CS) from PHT using 8 different supervised machine learning (ML) methods for the prediction. RESULTS: The trained models successfully classified PPGL, CS, and EHT from PHT with area under the curve (AUC) of 0.9 and PA from PHT with AUC 0.8 from the test set. The most prominent circulating miRNA features for hypertension identification of different disease combinations were hsa-miR-15a-5p and hsa-miR-32-5p. CONCLUSIONS: This study confirms the potential of circulating miRNAs to serve as diagnostic biomarkers for EHT and the viability of ML as a tool for identifying the most informative miRNA species.
No takes yet. Share an insight, caveat, or question.
Reel et al. (2025) conducted an observational in Hypertension. Circulating microRNA profiles and machine learning vs. Primary hypertension was evaluated on Classification of endocrine hypertension and its subtypes from primary hypertension (AUC 0.9 for PPGL, CS, and EHT; AUC 0.8 for PA). Machine learning models using circulating microRNA profiles successfully classified endocrine hypertension, PPGL, and Cushing's syndrome from primary hypertension with an AUC of 0.9.
Synapse has enriched 10 related papers. Consider them for comparative context: